Phenotypic modification of arterial smooth muscle cells in response to medial dissection

Coronary Artery Disease

Volumn 8, Issue 3-4, 1997, Pages 163-170

  Dufourcq, Pascale ^a   Louis, Huguette ^a   Dandré, Fréderic ^a   Lavie, Julie ^a   Bonnet, Jacques ^a   Lamazière, Jean Marie Daniel ^a  

^a INSERM   (France)

Author keywords

Angioplasty; Aorta; Dissection; Phenotype; Smooth muscle cells

Indexed keywords

CYCLINE; SCLEROPROTEIN;

ANGIOPLASTY; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTERY; ARTERY MUSCLE; ARTICLE; BLOOD VESSEL WALL; CONTROLLED STUDY; INTIMA; MALE; NONHUMAN; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; RABBIT; SMOOTH MUSCLE;

EID: 0030977445     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-199703000-00007     Document Type: Article

References (40)

1. Dotter CT, Judkins MP: Transluminal treatment of arteriosclerotic obstruction. Description of a new technique and a preliminary report of its applications. Circulation 1964, 30:654-670.
2. Bredlau CE, Roubin GS, Leimgruber PP, Douglas JS, King SB, Gruentzig AR: In-hospital morbidity and mortality in patients undergoing elective coronary angioplasty. Circulation 1985, 72:1044-1052.
3. Keren G, Pichard AD, Kent KM, Sutler LF, Leon MB: Failure or success of complex catheter-based interventional procedures assessed by intravascular ultrasound. Am Heart J 1992, 123:200-208.
4. Huber MS, Mooney JF, Madison J, Mooney MR: Use of a morphologic classification to predict clinical outcome after dissection from coronary angioplasty. Am J Cardiol 1991, 68:467-471.
5. Detre KM, Holmes DRJ, Holukhov R, Cowley MJ, Bourassa MG, Faxon DP, et al.: Incidence and consequences of periprocedural occlusion: the 1985-1986 national heart, lung, and blood insitute percutaneous transluminal coronary angioplasty registry. Circulation 1990, 82:739-750.
6. Ellis SG, Roubin GS, King SBI, Douglas JSJ, Schaw RE, Stertzer SH, et al.: In-hospital cardiac mortality after acute closure after coronary angioplasty: analysis of risk factors from 8207 procedures. J Am Coll Cardiol 1988, 11:211-216.
7. Herrmann WRM, Foley DP, Rensing BJ, Rutsch W, Heyndrickx GR, Danchin N, et al.: Usefulness of quantitative and qualitative angiographic lesion morphology, and clinical characteristics in predicting major adverse cardiac events during and after native coronary balloon angioplasty. Am J Cardiol 1993, 72:14-20.
8. Talley JD, Jones EL, Weintraub WS, King SBI: Coronary artery bypass surgery after failed elective percutaneous transluminal coronary angioplasty. Circulation 1989, 79 (suppl I):I126-I131.
9. Cowley MJ, Vetrovel GW, Wolfgang TC: Efficacy of percutaneous transluminal coronary angioplasty: technique, patient selection, salutary results, limitations and complications. Am Heart J 1981, 101:272-280.
10. Essed CE, Van Den Brand M, Becker AE: Transluminal coronary angioplasty and early restenosis: fibrocellular occlusion after wall laceration. Br Heart J 1983, 49:393-396.
11. Fleck E, Regitz V, Lenhert A, Dacian S, Dirschinger J, Rudolph W: Restenosis after balloon dilatation of coronary stenosis multivariate analysis of potential risk factors. Eur Heart J 1988, 9 (suppl C): 15-18.
12. Matthews BJ, Ewels CJ, Kent KM: Coronary dissection: a predictor of restenosis? Am Heart J 1988, 115:547-554.
13. Baumgartner HR: The role of blood flow and platelet adhesion, fibrin deposition and formation of mural thrombi. Microvasc Res 1973, 5:167-179.
14. Daniel Lamazière JM, Desmoulière A, Pascal M, Larrue J: Detection of atherosclerotic plaques with two monoclonal antibodies. Atherosclerosis 1988, 74:115-126.
15. Desmoulière A, Daniel Lamazière J-M, Larrue J: Phenotypic expression of surface antigens of rabbit aortic smooth muscle cells in culture: monoclonal antibody, 2P1A2, characteristic of smooth muscle cells present in atherosclerotic plaque, is not correlated with cell proliferation. Atherosclerosis 1990, 85:25-35.
16. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, et al.: Proliferation in primary and restenotic coronary atherectomy tissue: implications for antiproliferative therapy. Circ Res 1993, 73:223-231.
17. Hsu S, Raine L, Fanger H: Use of avidin-biotin peroxidase complex (ABC) in immunoperoxidase technique: a comparison between ABC and unlabeled antibody (PAP) procedures. J Histochem Cytochem 1981, 29:577-580.
18. Daniel Lamazière JM, Lavallee J, Zunino C, Larrue J: Semiquantitative study of the distribution of two cellular antigens by computer-directed color analysis. Lab Invest 1993, 68:248-252.
19. Faxon DP, Weber VJ, Haudenschild C, Gottsman SB, McGovern WA, Ryan TJ: Acute effects of transluminal angioplasty in three experimental models of atheroslcerosis. Arteriosclerosis 1982, 2:125-133.
20. Strauss BH, Chisholm RJ, Keeley FW, Gotlieb Al, Logan RA, Armstrong PW: Extracellular matrix remodeling after balloon angioplasty injury in a rabbit model of restenosis. Circ Res 1994, 75:650-658.
21. Block PC, Myler RK, Stertzer S, Fallon JT: Morphology after transluminal angioplasty angioplasty in human beings. N Engl J Med 1981, 305:382-385.
22. Sanborn TA, Faxon DP, Haudenschild C, Gottsman SB, Ryan TJ: The mechanism of transluminal angioplasty: evidence for formation of aneurysms in experimental atherosclerosis. Circulation 1983, 68:1136-1140.
23. Castaneda-Zuniga WR, Formanek A, Tadavarthy M, Vlodaver Z, Edwards JE, Zollikofer C, et al.: The mechanism of balloon angioplasty. Radiology 1980, 135:565-571.
24. Sarembock IJ, La Veau PJ, Sigal SL, Timms I, Sussman J, Haudenschild C, et al.: Influence of inflation pressure and balloon size on the development of intimai hyperplasia after balloon angioplasty. Circulation 1989, 80:1029-1040.
25. Campbell GR, Campbell JH: Smooth muscle phenotypic changes in arterial wall homeostasis: implications for the pathogenesis of atherosclerosis. Exp Mol Pathol 1985, 42:139-162.
26. Kocher O, Gabbiani F, Gabbiani G, Reidy MA, Cokay MS, Peters H, et al.: Phenotypic features of smooth muscle cells during the evolution of experimental carotid artery intimai thickening: biochemical and morphologic studies. Lab Invest 1991, 65:459-470.
27. Richardson M, Hatton MWC, Buchanan MR, Moore S: Wound healing in the media of the normolipemic rabbit carotid artery injured by air drying or by balloon catheter de-endothelialization. Am J Pathol 1990, 137:1453-1465.
28. Blank RS, Thompson MM, Owens GK: Cell cycle versus density dependence of smooth muscle alpha actin expression in cultured aortic smooth muscle cells. J Cell Biol 1988, 107:299-306.
29. Clowes AW, Reidy MA, Clowes MM: Mechanisms of stenosis after arterial injury. Lab Invest 1983, 49:208-215.
30. Helin P, Lorenzen I, Garbarsch C, Matthiessen ME: Repair in arterial tissue: morphological and biochemical changes in rabbit aorta after a single dilatation injury. Circ Res 1971, 29:542-554.
31. Schwartz RS, Holmes DR, Topol EJ: The restenosis paradigm revisited: an alternative proposal for cellular mechanisms. J Am Coll Cardiol 1992, 20:1284-1293.
32. Bravo R: Synthesis of the nuclear protein cyclin (PCNA) and its relationship with DNA replication. Exp Cell Res 1986, 163:287-293.
33. Clowes AW, Schwartz SM: Significance of quiescent smooth muscle migration in the injured rat carotid artery. Circ Res 1985, 56: 139-145.
34. Hanke H, Strohschneider T, Oberhoff M, Betz E, Karsch KR: Time course of smooth muscle cell proliferation in the intima and media of arteries following experimental angioplasty. Circ Res 1990, 67:651-659.
35. Fingerle J, Au YPT, Clowes AW, Reidy MA: Intimai lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis 1990, 10:1082-1087.
36. Lindner V, Reidy MA: Expression of basic fibroblast growth factor and its receptor by smooth muscle cells and endothelium in injured rat arteries. Circ Res 1993, 73:589-595.
37. Majesky MW, Reidy MA, Bowen-Pope DF, Hart CE, Wilcox JN, Schwartz SM: PDGF ligand and receptor gene expression during repair of arterial injury. J Cell Biol 1990, 111:2149-2158.
38. Lindner V, Olson NE, Clowes AW, Reidy MA: Inhibition of smooth muscle cell proliferation in injured rat arteries: interaction of heparin with basic fibroblast growth factor. J Clin Invest 1992, 90:2044-2049.
39. Lindner V, Reidy MA. Proliferation of smooth muscle cells after vascular injury is inhibited by an antibody against basic fibroblast growth factor. Proc Natl Acad Sci USA 1991, 88:3739-3743.
40. Gordon D, Reidy MA, Benditt EP, Schwartz SM: Cell proliferation in human coronary arteries. Proc Natl Acad Sci USA 1990, 87:4600-4604.